Onconova Therapeutics (ONTX) Reports Q3 Loss of $0.29/Share

Onconova Therapeutics (NASDAQ: ONTX) reported Q3 EPS of ($0.29), versus ($2.60) reported last year. Revenue for the quarter came in at $1.7 million, versus $1.6 million reported last year.

For earnings history and earnings-related data on Onconova Therapeutics (ONTX) click here.

You May Also Be Interested In

• Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
• UBS Reiterates Buy Rating on Cheniere Energy (LNG)
• Yext, Inc. (YEXT) Tops Q2 EPS by 4c